Literature DB >> 23735676

Post-operative elimination of sevoflurane anesthetic and hexafluoroisopropanol metabolite in exhaled breath: pharmacokinetic models for assessing liver function.

S Ghimenti1, F Di Francesco, M Onor, M A Stiegel, M G Trivella, C Comite, N Catania, R Fuoco, J D Pleil.   

Abstract

Sevoflurane (SEV), a commonly used anesthetic agent for invasive surgery, is directly eliminated via exhaled breath and indirectly by metabolic conversion to inorganic fluoride and hexafluoroisopropanol (HFIP), which is also eliminated in the breath. We studied the post-operative elimination of SEV and HFIP of six patients that had undergone a variety of surgeries lasting between 2.5 to 8.5 h using exhaled breath analysis. A classical three compartments pharmacokinetic model developed for the study of environmental contaminants was fitted to the breath data. We found that SEV kinetic behavior following surgery (for up to six days) is consistent across all subjects whereas the production and elimination of HFIP varies to some extent. We developed subject specific parameters for HFIP metabolism and interpreted the differences in the context of timing and dose of anesthesia, type of surgery, and specific host factors. We propose methods for assessing individual patient liver function using SEV as a probe molecule for assessing efficiency of liver metabolism to HFIP. This work is valuable not only for the clinical study of metabolism recovery, but potentially also for the study of the interaction of other manufactured and environmental compounds with human systems biology in controlled exposure and observational studies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23735676     DOI: 10.1088/1752-7155/7/3/036001

Source DB:  PubMed          Journal:  J Breath Res        ISSN: 1752-7155            Impact factor:   3.262


  3 in total

1.  A new hypothesis to investigate bioequivalence of pharmaceutical inhalation products.

Authors:  Maryam Khoubnasabjafari; Elaheh Rahimpour; Morteza Samini; Vahid Jouyban-Gharamaleki; Lan Chen; Donghao Chen; Hak-Kim Chan; Abolghasem Jouyban
Journal:  Daru       Date:  2019-03-07       Impact factor: 3.117

Review 2.  Evolution of clinical and environmental health applications of exhaled breath research: Review of methods and instrumentation for gas-phase, condensate, and aerosols.

Authors:  M Ariel Geer Wallace; Joachim D Pleil
Journal:  Anal Chim Acta       Date:  2018-02-09       Impact factor: 6.558

3.  Elimination characteristics of post-operative isoflurane levels in alveolar exhaled breath via PTR-MS analysis.

Authors:  R Fernández Del Río; M E O'Hara; P Pemberton; T Whitehouse; C A Mayhew
Journal:  J Breath Res       Date:  2016-10-12       Impact factor: 3.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.